These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29462798)

  • 1. Serum FGF21 Is Associated with Future Cardiovascular Events in Patients with Coronary Artery Disease.
    Shen Y; Zhang X; Xu Y; Xiong Q; Lu Z; Ma X; Bao Y; Jia W
    Cardiology; 2018; 139(4):212-218. PubMed ID: 29462798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Serum Fibroblast Growth Factor 21 and Mortality Among Patients With Coronary Artery Disease.
    Li Q; Zhang Y; Ding D; Yang Y; Chen Q; Su D; Chen X; Yang W; Qiu J; Ling W
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4886-4894. PubMed ID: 27662438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
    Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
    Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
    Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.
    Shen Y; Ma X; Zhou J; Pan X; Hao Y; Zhou M; Lu Z; Gao M; Bao Y; Jia W
    Cardiovasc Diabetol; 2013 Aug; 12():124. PubMed ID: 23981342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events.
    Wang CP; Lu LF; Yu TH; Hung WC; Chiu CA; Chung FM; Hsu CC; Lu YC; Lee YJ; Houng JY
    J Nephrol; 2013; 26(1):111-8. PubMed ID: 22460182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
    Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.
    Gazzaruso C; Solerte SB; Pujia A; Coppola A; Vezzoli M; Salvucci F; Valenti C; Giustina A; Garzaniti A
    J Am Coll Cardiol; 2008 May; 51(21):2040-4. PubMed ID: 18498958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Circulating Decoy Receptor 3 in Predicting Coronary Artery Disease Severity and Future Major Adverse Cardiovascular Events in Patients With Multivessel Coronary Artery Disease.
    Chang TY; Hsu CY; Huang PH; Chiang CH; Leu HB; Huang CC; Chen JW; Lin SJ
    Am J Cardiol; 2015 Oct; 116(7):1028-33. PubMed ID: 26254707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease.
    Yu J; Han J; Mao J; Guo L; Gao W
    Chin Med J (Engl); 2014; 127(6):1039-45. PubMed ID: 24622431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum FGF21 is an independent predictor for adverse events in hemodialysis patients from two large centers: a prospective cohort study.
    Li M; Jiang LQ; Zhang MY; Liu SS; Sawh RR; Zheng J; Yan Y; Hou SM; Lu KQ; Thorne O; Liu BC; Qian Q; Wu YF; Yang M; Wang B
    Ren Fail; 2023; 45(2):2256414. PubMed ID: 37724523
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention.
    Gu L; Jiang W; Qian H; Zheng R; Li W
    PeerJ; 2021; 9():e12235. PubMed ID: 34703671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status.
    Lee Y; Lim S; Hong ES; Kim JH; Moon MK; Chun EJ; Choi SI; Kim YB; Park YJ; Park KS; Jang HC; Choi SH
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):57-64. PubMed ID: 23278761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter study.
    Toutouzas K; Benetos G; Koutagiar I; Barampoutis N; Mitropoulou F; Davlouros P; Sfikakis PP; Alexopoulos D; Stefanadis C; Siores E; Tousoulis D
    Atherosclerosis; 2017 Jul; 262():25-30. PubMed ID: 28482222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum osteocalcin levels with major adverse cardiovascular events: A 4.4-year retrospective cohort study.
    Zhang X; Shen Y; Xu Y; Xiong Q; Lu Z; Ma X; Bao Y; Jia W
    Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):3-9. PubMed ID: 28921598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid SPECT Perfusion Imaging and Coronary CT Angiography: Long-term Prognostic Value for Cardiovascular Outcomes.
    Pazhenkottil AP; Benz DC; Gräni C; Madsen MA; Mikulicic F; von Felten E; Fuchs TA; Moch BH; Stehli J; Lüscher TF; Gaemperli O; Buechel RR; Kaufmann PA
    Radiology; 2018 Sep; 288(3):694-702. PubMed ID: 29969066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Fasting Serum Bilirubin Levels with Clinical Outcomes After Percutaneous Coronary Intervention: A Prospective Study.
    Zhang MM; Gao Y; Zheng YY; Chen Y; Liu F; Ma YT; Xie X
    Cardiovasc Toxicol; 2017 Oct; 17(4):471-477. PubMed ID: 28283905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
    Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum C-reactive protein levels predict cardiovascular events in the Japanese coronary artery disease (JCAD) study.
    Shimada K; Fujita M; Tanaka A; Yoshida K; Jisso S; Tanaka H; Yoshikawa J; Kohro T; Hayashi D; Okada Y; Yamazaki T; Nagai R;
    Circ J; 2009 Jan; 73(1):78-85. PubMed ID: 19015587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease.
    Wong YK; Cheung CYY; Tang CS; Au KW; Hai JSH; Lee CH; Lau KK; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2519-2527. PubMed ID: 30354221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.